Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for…

Overview of attention for article published in Osteoporosis International, March 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 97 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,099 followers.

#osteoporosis Denosumab significantly increases bone mineral density and reduces bone turnover compared with m... http://t.co/j1puP0S2oZ

Reply Repost Favourite

[Ost Int] Denosumab significantly increases bone mineral density and reduces bone turnover compared with month... http://t.co/4HvdVHjfMe

Reply Repost Favourite

Transition to #denosumab increases BMD & decreases CTX more than monthly oral #ibandronate or #risedronate http://t.co/nen6gMTbk2

Reply Repost Favourite

Transition to #denosumab increases BMD & decreases CTX more than monthly oral #ibandronate or #risedronate http://t.co/nen6gMTbk2

Reply Repost Favourite